<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The role of the complement system in mediating human <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">renal disease</z:e> has long been recognized in immune-complex excess syndromes such as <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> and in <z:e sem="disease" ids="C0268743" disease_type="Disease or Syndrome" abbrv="">dense deposit disease</z:e> in which no immunoglobulin (Ig) is present </plain></SENT>
<SENT sid="1" pm="."><plain>Over the past 15 years, mutations in complement regulatory genes have been demonstrated to predispose to <z:e sem="disease" ids="C0034155" disease_type="Disease or Syndrome" abbrv="">thrombotic microangiopathies</z:e> including atypical <z:hpo ids='HP_0005575'>hemolytic uremic syndrome</z:hpo>, C3 and C1q <z:hpo ids='HP_0100820'>glomerulopathies</z:hpo>, and <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Excessive complement activation on an endothelial cell, due to either an autoantibody or a regulatory <z:e sem="disease" ids="C0033626" disease_type="Disease or Syndrome" abbrv="">protein deficiency</z:e>, sets up a procoagulant state in these diseases as well as in the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Knowledge of the genes involved and the functional consequences of alterations in their structure has led to therapy that blocks complement activation </plain></SENT>
</text></document>